Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value ($000): $898,918 (100.0% shares, 0.0% debt)

Holdings (12)

BIIB BIOGEN INC 19.1%

Value ($000) $172,034 Shares 643,000 Est. Cost $278.12 Unrealized +8.1%

ALKS ALKERMES PLC 16.9%

Value ($000) $151,844 Shares 7,825,000 Est. Cost $18.71 Unrealized -13.2%

IRWD IRONWOOD PHARMACEUTICALS INC 16.1%

Value ($000) $144,892 Shares 14,040,000 Est. Cost $11.68 Unrealized -12.3%

JAZZ JAZZ PHARMACEUTICALS PLC 11.4%

Value ($000) $102,406 Shares 928,100 Est. Cost $128.37 Unrealized -13.9%

INVA INNOVIVA INC 10.0%

Value ($000) $89,667 Shares 6,414,000 Est. Cost $13.01 Unrealized +4.6%

— ALEXION PHARMACEUTICALS INC 9.3%

Value ($000) $83,450 Shares 743,500 Est. Cost $108.16 Unrealized —

— MERSANA THERAPEUTICS INC 6.7%

Value ($000) $60,138 Shares 2,570,000 Est. Cost $5.26 Unrealized —

— INTERCEPT PHARMACEUTICALS INC 6.4%

Value ($000) $57,539 Shares 1,201,000 Est. Cost $79.88 Unrealized —

ABBV ABBVIE INC 3.4%

Value ($000) $30,450 Shares 310,150 Est. Cost $70.40 Unrealized +0.1%

BCRX BIOCRYST PHARMACEUTICALS INC 0.6%

Value ($000) $5,122 Shares 1,075,000 Est. Cost $3.99 Unrealized 0.0%

— REGULUS THERAPEUTICS INC 0.1%

Value ($000) $1,262 Shares 1,851,851 Est. Cost $1.25 Unrealized —

— MIRATI THERAPEUTICS INC 0.0%

Value ($000) $114 Shares 1,000 Est. Cost $42.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BIIB	BIOGEN INC	643,000	$172,034	19.1%	$278.12	+8.1%	COM	09062X103
ALKS	ALKERMES PLC	7,825,000	$151,844	16.9%	$18.71	-13.2%	SHS	G01767105
IRWD	IRONWOOD PHARMACEUTICALS INC	14,040,000	$144,892	16.1%	$11.68	-12.3%	COM CL A	46333X108
JAZZ	JAZZ PHARMACEUTICALS PLC	928,100	$102,406	11.4%	$128.37	-13.9%	SHS USD	G50871105
INVA	INNOVIVA INC	6,414,000	$89,667	10.0%	$13.01	+4.6%	COM	45781M101
—	ALEXION PHARMACEUTICALS INC	743,500	$83,450	9.3%	$108.16	—	COM	015351109
—	MERSANA THERAPEUTICS INC	2,570,000	$60,138	6.7%	$5.26	—	COM	59045L106
—	INTERCEPT PHARMACEUTICALS INC	1,201,000	$57,539	6.4%	$79.88	—	COM	45845P108
ABBV	ABBVIE INC	310,150	$30,450	3.4%	$70.40	+0.1%	COM	00287Y109
BCRX	BIOCRYST PHARMACEUTICALS INC	1,075,000	$5,122	0.6%	$3.99	0.0%	COM	09058V103
—	REGULUS THERAPEUTICS INC	1,851,851	$1,262	0.1%	$1.25	—	COM NEW	75915K200
—	MIRATI THERAPEUTICS INC	1,000	$114	0.0%	$42.00	—	COM	60468T105